share_log

NanoViricides Provides An Update On Its Clinical Program And Strategy In Its Letter To Shareholder, Says NV-387, An Antiviral Drug, Could Be As Revolutionary As Antibiotics

Benzinga ·  Aug 8 19:46
NanoViricides Provides An Update On Its Clinical Program And Strategy In Its Letter To Shareholder, Says NV-387, An Antiviral Drug, Could Be As Revolutionary As Antibiotics
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment